The global alpha thalassemia market is experiencing significant growth due to increasing awareness regarding inherited blood disorders, advancements in genetic diagnostics, and the development of innovative treatment approaches. Alpha thalassemia is a hereditary blood disorder caused by reduced or absent production of alpha-globin chains, leading to anemia and other serious health...

The Hemoglobinopathies Market is developing as pharmaceutical companies expand their rare disease portfolios. Strategic collaborations are strengthening competitive positioning. The Hemoglobinopathies Market is witnessing strong expansion driven by increasing prevalence of inherited blood disorders, technological advancements in genetic therapies, and growing investments in rare disease...